Arkolith/Insider Trading/EKSO/Form 4

Sherman Steven

CEO & Chairman, DirectorEKSO BIONICS HOLDINGS, INC. (EKSO) · full profile →Form 4 · filed Oct 26, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 24, 2022Sell(S)6K$1.29$8K698K
Oct 21, 2022Option exercise(M)16K—$0704K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 21, 2022Option exercise(M)16K—$047K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001549084-22-000060) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML